Lipoprotein(a), Inflammation, and Risk of Coronary Artery Disease and Aortic Valve Stenosis

Дата публикации: 01-08-2026 00:00:00

This cohort study among UK Biobank participants assesses whether inflammatory biomarkers may modify lipoprotein(a)-associated risk for coronary artery disease and aortic stenosis in a primary prevention population.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Spectrum of Aldosteronism and Cardiovascular Outcomes	0	6.27	01-04-2026
2	Association of Lipoprotein(a) and Inflammation with In-Stent Restenosis Across Distinct Medication Adherence Phenotypes: An Exploratory Study Incorporating a "Natural Resistance" Population	0	16.41	10-08-2026
3	Twenty-Five–Year Follow-Up of Quantified Mitral Regurgitation	0	15.41	29-07-2026
4	Seven-Year Valve Durability With TAVR	0	11.52	01-08-2026
5	Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy	0	11.25	18-08-2026
6	Scientists discover a hidden heart valve risk linked to gum disease	0	5.38	13-07-2026
7	Toward a Lifetime Strategy for Aortic Valve Replacement—Ariadne’s Thread	0	7.65	01-08-2026
8	High Systemic Immune-Inflammation Index as a Predictor of In-Hospital and 30-Day Major Adverse Cardiovascular Events among Patients with STEMI and NSTEMI Undergoing Percutaneous Coronary Intervention: A Prospective Cohort Study	0	7	15-07-2026
9	Registry identifies gaps in care for patients with aortic stenosis	0	6.54	28-07-2026
10	UC Irvine researchers find differences between two causes of heart valve narrowing	0	9.15	22-01-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.36. Источник: jamanetwork.com.